Trends in diagnosis of pelvic inflammatory disease in an Australian sexual health clinic, 2002–16: before and after clinical audit feedback

Sexual Health ◽  
2019 ◽  
Author(s):  
Jane L. Goller ◽  
Christopher K. Fairley ◽  
Alysha M. De Livera ◽  
Marcus Y. Chen ◽  
Catriona S. Bradshaw ◽  
...  
2015 ◽  
Vol 91 (Suppl 2) ◽  
pp. A139.1-A139 ◽  
Author(s):  
JL Goller ◽  
CK Fairley ◽  
CS Bradshaw ◽  
AM De Livera ◽  
MY Chen ◽  
...  

Sexual Health ◽  
2010 ◽  
Vol 7 (4) ◽  
pp. 498 ◽  
Author(s):  
Yi Man Lee ◽  
Anil Samaranayake ◽  
Christopher K. Fairley ◽  
Marcus Y. Chen ◽  
Fiona MacFarlane ◽  
...  

The present study aimed to determine whether pelvic examinations change clinical management of women with asymptomatic chlamydia infection. Records for women with asymptomatic chlamydia who underwent a pelvic examination at a sexual health clinic in Melbourne, Australia (January 2006 to June 2007) were analysed retrospectively. Of 91 cases, 31 (34%) warranted examination; one woman (1%; 95% confidence interval: 0.5%, 6.4%) had muco-purulent cervicitis and mild tenderness, and was treated for possible pelvic inflammatory disease. These data suggest that a pelvic examination will lead to changes in treatment for very few women diagnosed with asymptomatic chlamydia infection.


Sexual Health ◽  
2016 ◽  
Vol 13 (1) ◽  
pp. 43 ◽  
Author(s):  
Jeannie Oliphant ◽  
Sunita Azariah

Background There is a paucity of studies looking at associations between Mycoplasma genitalium and pelvic inflammatory disease (PID). The objectives of this study were to estimate the prevalence of M. genitalium in women attending a sexual health service in New Zealand and secondly to examine for an association of M. genitalium with PID. Methods: Women consecutively attending the service for a sexual health screen (Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis) were recruited to establish a baseline prevalence of M. genitalium. An extra cervical swab was taken for the detection of M. genitalium. Recruitment of additional women with a clinical diagnosis of PID continued until a sufficient sample size was obtained to examine the association of PID with M. genitalium. Women in the baseline sample without PID were used as the control group. Results: The control group included 250 women, with M. genitalium diagnosed in 8.7% (95% CI 5.8–12.9%) and C. trachomatis in 9.9% (95% CI 6.8–14.2%). Ninety-one women were recruited with PID; M. genitalium was diagnosed in 9.9% (95% CI 5.3–17.7%) and C. trachomatis in 27.5% (95% CI 19.4–37.4%). Multivariate analysis using clinically relevant variables showed that a diagnosis of C. trachomatis (OR 2.44, 95% CI 1.24–4.81) but not M. genitalium (OR 0.91, 95% CI 0.38–2.20) was significantly associated with a PID diagnosis. Conclusions: M. genitalium was almost as commonly diagnosed as C. trachomatis in this population. C. trachomatis was the only infection that was significantly associated with PID.


2020 ◽  
Vol 71 (10) ◽  
pp. 2719-2722 ◽  
Author(s):  
Joanna Lewis ◽  
Paddy J Horner ◽  
Peter J White

Abstract We synthesized evidence from the POPI sexual-health cohort study and estimated that 4.9% (95% credible interval, .4–14.1%) of Mycoplasma genitalium infections in women progress to pelvic inflammatory disease versus 14.4% (5.9–24.6%) of chlamydial infections. For validation, we predicted PID rates in 4 age groups that agree well with surveillance data.


Sign in / Sign up

Export Citation Format

Share Document